 |
|
 |
| |
 |
|
Class Information
Number: 514/655
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai > Benzene ring containing > Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain > The aryl ring or aryl ring system and amino nitrogen are bonded directly to the same acylic carbon, which carbon additionally has only hydrogen or acyclic hydrocarbyl substituents bonded directly thereto
Description: Subject matter wherein an aryl ring or ring system and an amino nitrogen are both directly bonded to the same acyclic carbon which carbon additionally has only hydrogen or acyclic hydrocarbyl substituents bonded directly thereto.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7589127 |
Aminoalkylphenols, methods of using and making the same |
Sep. 15, 2009 |
| 7488759 |
Malic acid addition salts of terbinafine |
Feb. 10, 2009 |
| 7456222 |
Anti tubercular drug: compositions and methods |
Nov. 25, 2008 |
| 7300927 |
Method for treating or preventing Alzheimer's disease |
Nov. 27, 2007 |
| 7256204 |
Amine compounds, their production and use |
Aug. 14, 2007 |
| RE39530 |
3-amino-3-arylpropan-1-ol-compounds, their preparation and use |
Mar. 27, 2007 |
| 7119122 |
Compounds for the inhibition of nitric oxide synthase |
Oct. 10, 2006 |
| 6939895 |
Calcium receptor-active compounds |
Sep. 6, 2005 |
| 6924313 |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
Aug. 2, 2005 |
| 6919317 |
Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator |
Jul. 19, 2005 |
| 6890958 |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
May. 10, 2005 |
| 6881748 |
Drug targeting |
Apr. 19, 2005 |
| 6855711 |
Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators |
Feb. 15, 2005 |
| 6787570 |
Substituted N-cycloalkyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Sep. 7, 2004 |
| 6765023 |
Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jul. 20, 2004 |
| 6750255 |
Calcium receptor-active compounds |
Jun. 15, 2004 |
| 6723753 |
Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| 6723752 |
(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Apr. 20, 2004 |
| 6710089 |
Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Mar. 23, 2004 |
| 6710088 |
Inorganic ion receptor-active compounds |
Mar. 23, 2004 |
| 6696484 |
Method and compositions for regulation of 5-alpha reductase activity |
Feb. 24, 2004 |
| 6683115 |
.beta.2-adrenergic receptor agonists |
Jan. 27, 2004 |
| 6683099 |
Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 27, 2004 |
| 6683113 |
(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 27, 2004 |
| 6677380 |
Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 13, 2004 |
| 6677375 |
Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jan. 13, 2004 |
| 6635667 |
Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl |
Oct. 21, 2003 |
| 6613771 |
Method of treatment of viral infection including HIV using water soluble fullerenes |
Sep. 2, 2003 |
| 6583183 |
Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Jun. 24, 2003 |
| 6583182 |
Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis |
Jun. 24, 2003 |
| 6576660 |
Methods and compositions for regulation of 5-.alpha.-reductase activity |
Jun. 10, 2003 |
| 6559186 |
Compositions and methods of treatment of sympathetically maintained pain |
May. 6, 2003 |
| 6521607 |
(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
Feb. 18, 2003 |
| 6489366 |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
Dec. 3, 2002 |
| 6482862 |
Method of using substituted N-benzyl-N-phenyl aminoalcohols for inhibiting cholesteryl ester transfer protein activity |
Nov. 19, 2002 |
| 6476057 |
Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
Nov. 5, 2002 |
| 6476075 |
Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity |
Nov. 5, 2002 |
| 6462092 |
Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
Oct. 8, 2002 |
| 6462091 |
Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications |
Oct. 8, 2002 |
| 6462044 |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
Oct. 8, 2002 |
| 6458851 |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
Oct. 1, 2002 |
| 6458850 |
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
Oct. 1, 2002 |
| 6458849 |
use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activity |
Oct. 1, 2002 |
| 6455592 |
Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
Sep. 24, 2002 |
| 6455591 |
Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment |
Sep. 24, 2002 |
| 6448293 |
Diphenyl ether compounds useful in therapy |
Sep. 10, 2002 |
| 6448295 |
Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
Sep. 10, 2002 |
| 6432991 |
Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl |
Aug. 13, 2002 |
| 6423342 |
Process for the preparation of a solid pharmaceutical dosage form |
Jul. 23, 2002 |
| 6380236 |
Method of treating onychomycosis |
Apr. 30, 2002 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
